Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the ...
Closely related to the Neue Klasse iX3 up front, the next X5 and its full-electric iX5 sibling are underpinned by a new ...
The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Yescarta (axicabtagene ...
Garaherb Unveiled offers a fact-based 2026 overview of the Garaherb male supplement, including ingredients, safety, usage, ...
The receiver's on-field performance for the Patriots speaks louder than his habit of always walking barefoot and his desire ...
InGeneron, Inc., a biotechnology company pioneering autologous regenerative cell therapies, today announced receipt of a CE Certificate (No. 28620235524 issued January 19, 2026) for the Transpose ...
The mHawk diesel engine is a masterpiece of refinement. It has enough torque to make this heavy SUV feel light on its feet, ...
National caste census has triggered a Bhumihar reckoning. The community in Bihar is waging a new battle for colonial-era ...
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...
PCMag UK on MSN
Lenovo ThinkPad P14s Gen 6 (AMD)
None ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton's tyrosine kinase (BTK ...
American farmers hope to benefit from a U.S.-Malaysia trade deal, but finding buyers in a fiercely competitive landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results